Has Demetrous Johnston received payments from drug or device companies?

Yes. Drug and device makers reported $5,816 in general payments to Demetrous Johnston across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Demetrous Johnston did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Demetrous Johnston come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Demetrous Johnston

Psychiatric/Mental Health · Hampton, VANPI 1407460413

Payments from drug & device makers

$5,816in general payments, 2019–2025

Across 163 payments — averaging $35.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$2K
Johnson & Johnson$877
Alkermes, Inc.$742
AbbVie$704
Otsuka America Pharmaceutical, Inc.$584
Neurocrine Biosciences, Inc.$457
plus $773 from 10 others

What the payments were for

Food & beverage$5,72698%
Education$912%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	67	$1,679
Johnson & Johnson	14	$877
Alkermes, Inc.	23	$742
AbbVie	20	$704
Otsuka America Pharmaceutical, Inc.	13	$584
Neurocrine Biosciences, Inc.	7	$457
E.r. Squibb & Sons, L.L.C.	5	$261
Axsome Therapeutics, Inc.	2	$213
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$125
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$59
Sunovion Pharmaceuticals Inc.	2	$32
Ironshore Pharmaceuticals Inc.	1	$23
Takeda Pharmaceuticals U.S.A., Inc.	1	$18
Indivior Inc.	1	$16
Supernus Pharmaceuticals, Inc.	1	$15
Avanir Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,816 in reported general payments places this provider in the 90th percentile of 1,003 psychiatric/mental health providers in Virginia.

See all psychiatric/mental health providers in Virginia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	94	$334,736
Invega TrinzaPaliperidone Palmitate	22	$217,555
AustedoDeutetrabenazine	19	$105,746
Abilify AsimtufiiAripiprazole	16	$93,349
UzedyRisperidone	19	$72,464
Abilify MaintenaAripiprazole	24	$70,062
AristadaAripiprazole Lauroxil	20	$63,691
LybalviOlanzapine/Samidorphan Malate	15	$24,637
Aripiprazole	55	$11,698
TrintellixVortioxetine Hydrobromide	13	$7,340
Fluphenazine Hcl	69	$4,383
Divalproex Sodium	79	$3,899
Divalproex Sodium ErDivalproex Sodium	80	$3,538
Haloperidol	65	$3,411
Olanzapine	87	$2,808

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza	$877	$552,291116 claims
Teva Pharmaceuticals USA, Inc.Austedo, Uzedy	$1,679	$178,21038 claims
Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Abilify Maintena	$584	$163,41140 claims
Alkermes, Inc.Aristada, Lybalvi	$742	$88,32835 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$18	$7,34013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,003 psychiatric/mental health providers in Virginia.

Other psychiatric/mental health in Hampton

Craig TysonHampton$15K
Justin RayChesapeake$127K
Katia HallChesapeake$88K
Christine GilmoreBedford$75K
Sarah FaberNewport News$59K
Kristine GarciaGlen Allen$46K
Tonjanika BoydRichmond$40K
Kirby PatmonRichmond$36K
Juliana FroschAmherst$36K
Derick ReedyNickelsville$23K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →